Skip to main content
ISTH 2023 Main banner
Back

    Thomas A. Mavrakanas, MD, MSc

    Assistant Professor of Medicine at McGill University
    Division of Nephrology, Department of Medicine, McGill University Health Center and Research Institute, Montreal, QC, Canada
    Montreal, Quebec, Canada

    Thomas A. Mavrakanas, MD, MSc, FRCPC, FASN
    Assistant Professor of Medicine and Attending Nephrologist, Department of Medicine, McGill University Health Centre & Research Institute, Montreal, QC, Canada
    My research focuses on the causes of and treatments for cardiovascular disease in patients with chronic kidney disease (CKD) and kidney failure. My work aims to optimize management of patients with chronic kidney and cardiovascular disease in order to prevent occurrence of myocardial infarction, stroke, or admission for heart failure, as well as to slow down CKD progression to kidney failure. I was the first scientist to study the pharmacokinetics of apixaban, a direct oral anticoagulant, at steady state in patients on maintenance dialysis and to compare clinical outcomes of this agent with no anticoagulation in this population. I am currently studying the coagulation disorders in patients with active glomerular disorders and nephrotic range proteinuria.

    Presentation(s):